THERORNA
Live / Registered — Registered (as of 12 Sept 2023)
What this means for you
Registered since 12 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90796130
- Registration number
- 7159975
- Mark type
- Word mark
- Filed
- 25 Jun 2021
- Published for opposition
- 27 Jun 2023
- Registered
- 12 Sept 2023
- Attorney of record
- Paulo A. de Almeida
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human biomedicine, namely, pharmaceutical preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; vaccines; drugs for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; opotherapy preparations; serotherapeutic medicines, namely, medical immune serums used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; biological preparations for medical purposes, namely, biological preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; medicines for human purposes, namely, medicines used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; chemical preparations for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; adjuvants for medical purposes; Blood for medical purposes; nutraceutical preparations for therapeutic or medical purposes; immunostimulants; Medical cell function activating drugs, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; tumor suppressing agents; Anti-sarcoma preparations; cytostatics for medical purposes; Pharmaceutical products for the prevention and treatment of cancer; all the foregoing using circular ribonucleic acid (RNA)
Owner
- THERORNA Inc, Haidian Dist., Beijing, CN
- THERORNA Inc, Haidian Dist., Beijing, CN
- THERORNA Inc, Haidian Dist., Beijing, CN
Prosecution history
- 12 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 27 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Jun 2023 — PUBLISHED FOR OPPOSITION
- 07 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 May 2023 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 12 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 May 2023 — EXAMINER'S AMENDMENT ENTERED
- 12 May 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 May 2023 — EXAMINERS AMENDMENT E-MAILED
- 12 May 2023 — EXAMINERS AMENDMENT -WRITTEN
- 01 Nov 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Nov 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Nov 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Sept 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE